N
AXNX

Natixis’s Axonics, Inc. Common Stock AXNX Stock Holding History

Natixis’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48,872
Closed -$3.4M – 1222
2024
Q3 		$3.4M Buy
48,872
+23,000
+89% +$1.58M 0.02% 359
2024
Q2 		$1.74M Buy
25,872
+17,454
+207% +$1.18M 0.01% 437
2024
Q1 		$581K Sell
8,418
-3,068
-27% -$207K ﹤0.01% 604
2023
Q4 		$715K Sell
11,486
-10,032
-47% -$561K 0.01% 573
2023
Q3 		$1.21M Sell
21,518
-3,420
-14% -$192K 0.01% 473
2023
Q2 		$1.26M Sell
24,938
-140
-0.6% -$7.45K 0.01% 500
2023
Q1 		$1.37M Buy
25,078
+15,952
+175% +$932K 0.01% 478
2022
Q4 		$571K Sell
9,126
-47,403
-84% -$3.15M ﹤0.01% 699
2022
Q3 		$4.07M Sell
56,529
-22,208
-28% -$1.53M 0.02% 459
2022
Q2 		$4.47M Buy
78,737
+36,712
+87% +$2.01M 0.02% 472
2022
Q1 		$2.63M Buy
42,025
+4,683
+13% +$252K 0.01% 686
2021
Q4 		$2.09M Sell
37,342
-610
-2% -$37.3K 0.01% 762
2021
Q3 		$2.47M Sell
37,952
-2,777
-7% -$190K 0.01% 685
2021
Q2 		$2.58M Sell
40,729
-675
-2% -$39.8K 0.01% 484
2021
Q1 		$2.48M Buy
+41,404
New +$2.25M 0.01% 650

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Natixis's AXNX Position: Q4 2024 in Review

Natixis sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 48,872 shares — an estimated $3.4M sold.

Natixis first reported a position in AXNX in Q1 2021 and held it in 15 quarters. The position peaked at $4.47M in Q2 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Natixis reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Natixis sold 48,872 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $3.4M.
  • Natixis first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
  • Natixis's Axonics, Inc. Common Stock position peaked at $4.47M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Natixis's 13F filing for Q4 2024, filed 13 Feb 2025.